Name | MUNITSIPAL'NOE UNITARNOE PREDPRIYATIE APTEKA N19 |
---|
INN | 7515000484 |
---|
KPP | 751501001 |
---|
OGRN | 1027500681581 |
---|
OKPO | 1905430 |
---|
Address | 674500, kray Zabaykal'skiy, r-n Olovyanninskiy, pgt Olovyannaya, ul. Moskovskaya, d. D.54 |
---|
Phone | 4-55-31 Contact details |
|
OKVED code | Type | Name of activity type |
---|
47.73 | Core activity | Retailing drugs in specialized stores (pharmacies) |
Registration date | 24.09.2002 |
---|
Registering department | Munitsipal'noe uchrezhdenie Administratsiya Olovyanninskogo rayona Chitinskoy oblasti |
---|
|
MUP APTEKA N19 (Zabaykalsky Krai; INN 7515000484) was registered on 24 Sep 2002. The company's authorized capital as of July 1, 2012 was 100000 rub. Type of ownership of MUP APTEKA N19 - Unitary enterprises based on the principle of economic management. Form of ownership of MUP APTEKA N19 - Municipal property. Principal activities of MUP APTEKA N19: retailing drugs in specialized stores (pharmacies) (47.73). |
Economic indicators2022
Net loss (RA) of MUP APTEKA N19 made up 449.00 thousand RUB over 2022 compared to net profit of 718.00 thousand RUB over 2021, the company informed. Revenue decreased in the accounting period by 13.84% to 35.16 million RUB from 40.81 million RUB in 2021; cost of goods sold decreased by 14.91% to 25.12 million RUB from 29.52 million RUB; sales loss made up 893.00 thousand RUB compared to sales profit of 699.00 thousand RUB. 2021
Net profit (RAS) of MUP APTEKA N19 dropped in 2021 by 24.26% to 718.00 thousand RUB from 948.00 thousand RUB over the same period in 2020, the company informed. Revenue increased in the accounting period by 5.27% to 40.81 million RUB from 38.77 million RUB over 2020; cost of goods sold grew by 8.54% to 29.52 million RUB from 27.20 million RUB; sales profit fell by 25.24% to 699.00 thousand RUB from 935.00 thousand RUB. 2020
Net profit (RAS) of MUP APTEKA N19 made up 948.00 thousand RUB over 2020 compared to net loss of 1.05 million RUB over 2019, the company informed. Revenue increased in the accounting period by 15.44% to 38.77 million RUB from 33.58 million RUB over 2019; cost of goods sold grew by 12.58% to 27.20 million RUB from 24.16 million RUB; sales profit made up 935.00 thousand RUB compared to sales loss of 987.00 thousand RUB. 2019
Net loss (RAS) of MUP APTEKA N19 increased 1.54 times to 1.05 million RUB from 682.00 thousand RUB over 2018, the company informed. Revenue increased in the accounting period by 6.62% to 33.58 million RUB from 31.50 million RUB over 2018; cost of goods sold grew by 8.41% to 24.16 million RUB from 22.28 million RUB; sales loss grew by 42.42% to 987.00 thousand RUB from 693.00 thousand RUB. 2018
Net loss (RA) of MUP APTEKA N19 made up 684.00 thousand RUB over 2018 compared to net profit of 1.74 million RUB over 2017, the company informed. Revenue decreased in the accounting period by 2.95% to 31.50 million RUB from 32.46 million RUB in 2017; cost of goods sold decreased by 3.10% to 22.28 million RUB from 23.00 million RUB; sales loss made up 693.00 thousand RUB compared to sales profit of 2.16 million RUB. 2017
Net profit (RAS) of MUP APTEKA N19 grew over 2017 14.14 times to 1.74 million RUB from 123.00 thousand RUB over 2016, the company informed. Revenue increased in the accounting period by 11.67% to 32.46 million RUB from 29.06 million RUB over 2016; cost of goods sold grew by 11.47% to 23.00 million RUB from 20.63 million RUB; sales profit went up 15.75 times to 2.16 million RUB from 137.00 thousand RUB. 2016
Net profit (RAS) of MUP APTEKA N19 dropped in 2016 5.41 times to 123.00 thousand RUB from 665.00 thousand RUB over the same period in 2015, the company informed. Revenue increased in the accounting period by 6.58% to 29.06 million RUB from 27.27 million RUB over 2015; cost of goods sold grew by 6.26% to 20.63 million RUB from 19.41 million RUB; sales profit fell 4.41 times to 137.00 thousand RUB from 604.00 thousand RUB. 2014
Net profit (RAS) of MUP Apteka N19 dropped in 2014 by 20.77% to 721.00 thousand RUB from 910.00 thousand RUB over the same period in 2013, the company informed. Revenue increased in the accounting period by 9.16% to 25.69 million RUB from 23.53 million RUB over 2013; cost of goods sold grew by 8.54% to 18.14 million RUB from 16.72 million RUB; sales profit made up 275.00 thousand RUB compared to sales loss of 214.00 thousand RUB. 2013
Net profit (RAS) of MUP Apteka N19 grew over 2013 by 6.93% to 910.00 thousand RUB from 851.00 thousand RUB over 2012, the company informed. Revenue increased in the accounting period by 12.12% to 23.53 million RUB from 20.99 million RUB over 2012; cost of goods sold grew by 11.81% to 16.72 million RUB from 14.95 million RUB; sales loss grew 5.35 times to 214.00 thousand RUB from 40.00 thousand RUB. 2012
Net profit (RAS) of MUUP APTEKA N 19 grew over 2012 by 13.32% to 851.00 thousand RUB from 751.00 thousand RUB over 2011, the company informed. Cost of goods sold grew by 11.39% to 14.95 million RUB from 13.42 million RUB; sales loss grew by 11.11% to 40.00 thousand RUB from 36.00 thousand RUB.
unlimited access to database "Kontragent" download any information within 24 hours
Companies in the region
|